从VAE生成的潜空间中发现人口PK共变量
概括
这项研究引入了一个新的VAE-LASSO框架,以确定影响药物行为的关键患者因素. 这种数据驱动的方法通过发现关键的药物动力学共变量来增强个性化医疗.
科学领域:
- 药理动力学和药理动力学
- 计算生物学和生物信息学
- 机器学习在药物开发中的作用
背景情况:
- 种群药动力学 (PopPK) 建模对于个性化剂量和改善治疗结果至关重要.
- 在PopPK数据中识别复杂的非线性共变量关系对传统方法来说是一个重大挑战.
- 现有的方法可能会忽略高维的药理动力学数据集中的隐藏模式.
研究的目的:
- 开发和验证一个数据驱动的,无模型的框架,用于发现人群药物动力学分析中的关键共变量.
- 将深度学习 (变量自编码器) 与稀疏回归 (LASSO) 整合起来,以实现可靠的共变量识别.
- 将VAE-LASSO方法应用于模拟的塔克罗利斯的药物动力学概况,用于临床共变体的发现.
主要方法:
- 利用变化自编码器 (VAE) 将高维的药物动力学信号压缩成结构化的潜空间,实现精确的数据重建 (2.26% MAPE).
- 使用LASSO回归与L1调整进行稀疏特征选择,将患者特定的共变量映射到VAE的潜在空间.
- 系统评估了VAE-LASSO框架在不同调节强度中识别和保留临床相关共变量的能力.
主要成果:
- 通过VAE-LASSO方法,成功地确定了影响塔克罗利斯药理动学的关键共变量,包括SNP,年龄,白蛋白和血红蛋白.
- 非信息性特征被有效地抛弃,证明了该方法在特征选择中的精确性.
- 该框架在不同规范化水平上一致确定了相关的共变量,突出显示了其稳定性.
结论:
- 拟议的VAE-LASSO框架提供了一个可扩展,可解释和完全基于数据的解决方案,用于药理动力学研究中的共变量选择.
- 这种方法对通过改善治疗药物监测来推进药物开发和精密药物治疗具有重大前景.
- 这种方法的可适应性使其适用于多种人群的药理动力学研究,可能提高患者治疗效率.
相关概念视频
Analysis of Population Pharmacokinetic Data
657
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
657
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
297
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
297
Model Approaches for Pharmacokinetic Data: Compartment Models
504
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
504
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
463
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
463
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K


